Hematology
The Risk of VTE in Women With Sickle Cell Disease
People with sickle cell disease (SCD) are at an increased risk of venous thromboembolism (VTE). Women, in particular, with SCD may be at a higher risk of blood clots than their male counterparts due to other risk factors, such as contraceptives or hormone therapies containing estrogen. People with sickle cell disease (SCD) face the possibility...
Assessing Patient-Reported Barriers to Sickle Cell Disease Treatment
Patients with sickle cell disease (SCD) often face inadequate care, which can lead to unnecessary hospital visits and preventable complications. Barriers to care for patients with SCD span individual, interpersonal, provider, and socio-environmental levels. Sickle cell disease (SCD) is a severe, inherited disorder that disproportionately affects African Americans in the United States. Despite available treatments,...
How Would a Cure Affect Sickle Cell Disease Inequities?
Economic disparities are higher across patients with SCD compared to the population without SCD, and these disparities may worsen existing racial disparities. One analysis simulated the effect of a cure on the financial well-being of patients with SCD. Economic disparities exist across patients with sickle cell disease (SCD), especially those of different racial and socioeconomic...
Disparities in Palliative Care Among Sickle Cell Disease Patients
Palliative care can help decrease symptoms and improve the quality of care of patients with sickle cell disease, especially those who are hospitalized. However, the use of palliative care can vary across different populations of hospitalized patients with sickle cell disease. Sickle cell disease (SCD) is a serious, inherited blood disorder characterized by chronic complications,...
Ethnic Disparities in Sickle Cell Disease
Although sickle cell disease is a monogenic condition, ethnicity and race may have an impact on the variability in clinical phenotypes of the disease. Understanding the link between ethnicity of SCD patients and the presentation of the disease could help guide clinicians to improved therapeutic interventions. Sickle cell disease (SCD) is one of the...
MoCA as a Cognitive Screening Tool in Sickle Cell Disease
Cognitive impairment in adults with sickle cell disease (SCD) poses a serious morbidity concern. Routine cognitive screening is encouraged by guidelines; however, no screening method has been shown effective in the population. The Montreal Cognitive Assessment (MoCA) was investigated as a potential screening tool for SCD. Researchers tested people with SCD on the MoCA, the...
Sickle Cell Webcast: Breakthroughs in Sickle Cell Treatment & Management
On June 27 MD Newsline hosted a sickle cell webcast featuring De. Cheryl Mensah and Dr. Krystal Preston moderated by Dr. Pete Thomas entitled “Breakthroughs in Sickle Cell Treatment & Management”. This webcast was sponsored by Oxbryta and Global Blood Therapeutics. Register via the image or link below to view the webcast. Sickle Cell Webcast...
Dr. Alecia Nero: Providing Culturally Sensitive Care
In this MD Newsline exclusive interview with Dr. Alecia Nero, hematologist and associate professor in internal medicine and pediatrics at UT Southwestern Medical Center, we discuss how to provide culturally sensitive care and overcome language barriers. Dr. Nero is the Director of UT Southwestern’s Transition Sickle Cell Program and Adult Sickle Cell Program. UT...
Dr. Alecia Nero: Sickle Cell Disease and COVID-19
In this MD Newsline exclusive interview with Dr. Alecia Nero, hematologist and associate professor in internal medicine and pediatrics at UT Southwestern Medical Center, we discuss challenges and disparities in sickle cell disease (SCD) care during the COVID-19 pandemic. Dr. Nero is the Director of UT Southwestern’s Transition Sickle Cell Program and Adult Sickle Cell...
More Medical News
